Recent observations on central nervous system lupus erythematosus

Area of Science:

• Rheumatology
• Neurology
• Psychiatry

Background:

• Central nervous system systemic lupus erythematosus (CNS-SLE) presents complex neurological and psychiatric challenges.
• Historically, CNS-SLE prognosis has been guarded, with varied etiologies contributing to symptoms.

Purpose of the Study:

• To review recent literature on CNS-SLE, focusing on prognosis and treatment advancements.
• To analyze the causes of neuropsychiatric symptoms in CNS-SLE, differentiating between corticosteroids and cerebral vasculitis.
• To present new patient data and evaluate combined treatment strategies.

Main Methods:

• Literature review of CNS-SLE.
• Analysis of neurologic and psychiatric findings, distinguishing organic psychoses from functional complaints.
• Examination of immunologic markers (HL-A antigens, complement, immunoglobulins, immunocomplexes) and potential infectious agents.
• Clinical review of 54 previously unreported patients with CNS-SLE, 38 exhibiting neuropsychiatric manifestations.

Main Results:

• Improved prognosis in CNS-SLE is associated with high-dose corticosteroid use.
• Immunocomplexes are implicated in CNS-SLE pathogenesis, with a potential role for infectious agents.
• A significant proportion of patients (38/54) presented with neuropsychiatric symptoms.

Conclusions:

• Clear psychiatric diagnosis and treatment are crucial for managing CNS-SLE.
• Combined therapy with corticosteroids and cytotoxic agents shows promise for treating CNS-SLE.
• Further investigation into infectious etiologies for SLE is warranted.